Treatment could save half of all terminal patients
Half of patients suffering deadly cancers could make full recoveries thanks to a new treatment which has stunned doctors with its success.
Half of patients suffering deadly cancers could make full recoveries thanks to a new treatment which has stunned doctors with its success.
Pint of Science is coming to Southampton and we are excited that our own Professor Peter Johnson and Dr Chern Lee will be presenting their immunology and immunotherapy research on Monday 18th May at The Juniper Berry pub. Learn more about how your own body could be the key to curing cancer direct from the Chief Clinician of CRUK. Tickets are only £3. Support the campaign whilst enjoying a night out at the pub.
A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton.
More than 70 University students and staff are taking on the race to cure cancer by hitting the roads in the ABP Southampton Half Marathon.
CRT and Bioinvent expand collaboration with University of Southampton scientists to develop new immunotherapy treatments for cancer.
Following promising pre-clinical trials at the University of Southampton, BiolnventÕs B1-1206 (a new fully-human antibody) is to enter a collaborative phase I/II for patients with chronic lymphocytic leukaemia and non Hodgkin lymphoma.